Companies

Covista Inc.

ATGE · CIK 0000730464 · operating

$98.54+1.97%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$3.58B
P/E14.51
Fwd P/E10.65
PEG
P/S1.90
P/B2.48
EV/EBITDA9.58
EV/Rev2.18

Profitability

Gross Margin
Op. Margin19.10%
Net Margin13.26%
ROE16.54%
ROA8.61%
FCF Margin16.08%

Financial Health

Current Ratio0.82
Debt/Equity0.92
Free Cash Flow$287.57M
Div. Yield

Growth & Other

Revenue Growth12.85%
EPS Growth82.30%
Beta0.71
52W High$156.26
52W Low$86.26

About Covista Inc.

Covista Inc. operates as a provider of healthcare and professional education services, offering degree and non-degree programs across nursing, medicine, veterinary medicine, and related health professions fields. The company delivers bachelor's, master's, and doctoral degrees alongside online certificate programs. Its educational offerings also extend to business, information technology, psychology, public health, social work, criminal justice, and public administration, primarily through distance and online delivery models.

The company's operations are organized into three segments: Chamberlain, which focuses on nursing and health professions education; Walden, which serves graduate and professional education markets; and Medical and Veterinary, which encompasses medical and veterinary schools. The Medical and Veterinary segment operates American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. These institutions serve students across the United States, Barbados, St. Kitts, and St. Maarten.

With approximately 4,700 full-time employees, Covista maintains its headquarters in Chicago, Illinois. The company was incorporated in Delaware in 1987 and previously operated under the name Adtalem Global Education Inc. before rebranding to Covista Inc. in February 2026. The company is listed on the NYSE.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$6.18$6.39+82.3%
2024$3.39$3.47+65.4%
2023$2.05$2.08+1038.9%
2022$0.18$0.18-87.9%
2021$1.49$1.50+130.7%
2020$-4.86$-4.90-665.1%
2019$0.86$0.88-15.7%
2018$1.02$1.03+52.2%
2017$0.67$0.68+518.8%
2016$-0.16$-0.16-134.8%
2015$0.46$0.46-77.8%
2014$2.07$2.09+25.5%
2013$1.65$1.66-21.1%
2012$2.09$2.11-55.3%
2011$4.68$4.73

Annual Reports (10-K) · 10 filings

Report DateFiledAccession Number
2025-06-302025-08-070001558370-25-010780SEC ↗
2024-06-302024-08-060001558370-24-011099SEC ↗
2023-06-302023-08-100001558370-23-014509SEC ↗
2022-06-302022-08-110001558370-22-013289SEC ↗
2021-06-302021-08-190001558370-21-011957SEC ↗
2020-06-302020-08-180001558370-20-010728SEC ↗
2019-06-302019-08-280001558370-19-008351SEC ↗
2018-06-302018-08-240001144204-18-046216SEC ↗
2017-06-302017-08-240001144204-17-044976SEC ↗
2016-06-302016-08-250001144204-16-121173SEC ↗